Eli Lilly Stock Surges After FDA Approves Weight-Loss Pill - At $25 To $149 Per Month
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily (IBD) provides information solely for educational and informational purposes and does not constitute investment advice or recommendations to buy or sell securities.
- The data presented is sourced from what IBD believes to be reliable, but accuracy, timeliness, and suitability are not guaranteed, and past performance is not indicative of future results.
- Authors and presenters may hold positions in the stocks they discuss, and IBD disclaims any warranties regarding the advisability of specific investments or strategies.
- Real-time price data is provided by Nasdaq Last Sale and may not cover all markets, with ownership and estimate data supplied by LSEG and FactSet respectively.
- All trademarks mentioned, including IBD-related brands, are owned by Investor’s Business Daily, LLC, which reserves all rights to its content and information.
